Table 2.
Subject demographics and baseline characteristics
| Parameter | Cannabidiol dose, mg/kg | |||||
|---|---|---|---|---|---|---|
| 5 (N = 6) | 10 (N = 6) | 20 (N = 6) | Total (N = 18) | Placebo (N = 6) | All subjects (N = 24) | |
| Mean age, years (SD) | 25.8 (5.2) | 25.0 (5.5) | 23.3 (6.6) | 24.7 (5.6) | 31.3 (9.8) | 26.4 (7.2) |
| Gender, n (%) | ||||||
| Male | 4 (67%) | 5 (83%) | 5 (83%) | 14 (78%) | 3 (50%) | 17 (71%) |
| Female | 2 (33%) | 1 (17%) | 1 (17%) | 4 (22%) | 3 (50%) | 7 (29%) |
| Race, n (%) | ||||||
| Asian | – | 1 (17%) | 3 (50%) | 4 (22%) | 2 (33%) | 6 (25%) |
| White | 6 (100%) | 5 (83%) | 3 (50%) | 14 (78%) | 4 (67%) | 18 (75%) |
| Ethnicity, n (%) | ||||||
| Hispanic/Latino | 2 (33%) | 1 (20%) | 1 (33%) | 4 (29%) | – | 4 (22%) |
| Not Hispanic/Latino | 4 (67%) | 5 (83%) | 5 (83%) | 14 (78%) | 6 (100%) | 20 (83%) |
| Mean BMI, kg/m2 (SD) | 23.1 (2.7) | 23.5 (2.1) | 23.4 (4.2) | 23.3 (2.9) | 25.3 (4.0) | 23.8 (3.2) |
BMI body mass index, N number of subjects, SD standard deviation